Oncology PracticeVIDEO: Pertuzumab prolongs disease-free survival in HER2+ early breast cancerJune 7, 2017Breast Cancer
Hematology TimesAddition of ublituximab to ibrutinib improves response in r/r CLLJune 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Oncology PracticePrimary care involvement improves chance of meeting recommended surveillance intervalsJune 6, 2017GastroenterologyPreventive CareGastrointestinal Cancer
Oncology PracticeVIDEO: Immunotherapy ups disease control rate in relapsed mesotheliomaJune 6, 2017Lung CancerImmuno-oncology
Oncology PracticeVIDEO: Alectinib doubles PFS and then some over crizotinib in ALK+ NSCLCJune 6, 2017Lung Cancer
Oncology PracticeVIDEO: Combined immunotherapy strategy shows promise in advanced solid tumorsJune 6, 2017Immuno-oncologyImmunotherapy
Oncology PracticeTRK inhibitor shows ‘striking’ activity, durability across diverse adult and pediatric cancersJune 5, 2017Sarcoma & GISTMelanomaGastroenterologyRare DiseasesGastrointestinal Cancer
Oncology PracticeVIDEO: Survival improves when cancer patients self-report symptomsJune 5, 2017Breast CancerGenitourinary CancerGynecologic CancerLung CancerPatient & Survivor Care
Oncology PracticeVIDEO: Routine genomic testing identifies actionable alterations in 52% of tumorsJune 5, 2017Gynecologic CancerHead & Neck/Thyroid CancersBreast CancerSarcoma & GISTCNS/Brain CancerGastroenterologyGastrointestinal Cancer
Oncology PracticeImmune-agonist combo has activity against several tumor typesJune 5, 2017Immuno-oncologyImmunotherapyBreast CancerMelanomaRenal Cell CarcinomaGynecologic CancerGenitourinary Cancer
Oncology PracticeBiomarker predicts prolonged depression in breast cancer patientsJune 5, 2017Breast Cancer
Hematology TimesCAR T cells elicit durable, potent responses in kids with EM relapse of ALLJune 5, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
